Oppenheimer & Co’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,920
| Closed | -$210K | – | 1312 |
|
|
2019
Q2 | $210K | Sell |
3,920
-245
| -6% | -$13.1K | 0.01% | 1165 |
|
|
2019
Q1 | $230K | Sell |
4,165
-650
| -13% | -$35.9K | 0.01% | 1161 |
|
|
2018
Q4 | $227K | Buy |
4,815
+100
| +2% | +$4.71K | 0.01% | 1057 |
|
|
2018
Q3 | $281K | Sell |
4,715
-436
| -8% | -$26K | 0.01% | 1092 |
|
|
2018
Q2 | $282K | Buy |
+5,151
| New | +$282K | 0.01% | 1081 |
|
|
2015
Q2 | – | Sell |
-6,104
| Closed | -$337K | – | 1531 |
|
|
2015
Q1 | $337K | Sell |
6,104
-1,863
| -23% | -$103K | 0.01% | 1056 |
|
|
2014
Q4 | $400K | Buy |
7,967
+625
| +9% | +$31.4K | 0.01% | 913 |
|
|
2014
Q3 | $339K | Buy |
7,342
+526
| +8% | +$24.3K | 0.01% | 1020 |
|
|
2014
Q2 | $298K | Buy |
6,816
+995
| +17% | +$43.5K | 0.01% | 1056 |
|
|
2014
Q1 | $242K | Sell |
5,821
-226
| -4% | -$9.4K | 0.01% | 1142 |
|
|
2013
Q4 | $224K | Buy |
+6,047
| New | +$224K | 0.01% | 1158 |
|